Highlights AViTA Corporation

Equities

4735

TW0004735006

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
41.4 ^TWD	+0.61%		+10.40%	+12.65%

Jun. 06	Avita Medical’s Cell Harvesting Device Treats First US Patient; Shares Rise 5%	MT
May. 31	Avita Medical's Recell Go Obtains Approval from US FDA	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Avita Medical’s Cell Harvesting Device Treats First US Patient; Shares Rise 5%	Jun. 05	MT
Sector Update: Health Care Stocks Mixed Late Afternoon	May. 30	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	May. 30	MT
Avita Medical Shares Rise After FDA Nod For Recell Go System	May. 30	MT
Sector Update: Health Care	May. 30	MT
Avita Medical Receives FDA Premarket Approval Supplement for Recell Go System	May. 30	MT
AViTA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	May. 13	MT
Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals	Apr. 10	MT
AViTA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday on Expected Rate Cut Trajectory Insights	Jan. 11	MT
Avita Medical Signs US Distribution Agreement for Wound Healing Products	Jan. 11	MT
Avita Medical Signs Deal with Stedical Scientific for US Distribution of PermeaDerm	Jan. 10	MT
Avita Medical Lowers Guidance for 2023 Commercial Revenue	Nov. 20	MT
AViTA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Avita Medical Widens Q3 Loss as Sales, Marketing Costs Rise; Shares Climb 17%	Nov. 09	MT
AVITA Medical Logs 50% Jump in Q3 Revenue; Maintains 2023 Guidance	23-10-19	MT
AViTA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Avita Medical Widens Fiscal Q2 Loss on Higher Marketing Costs; Shares Rise 3%	23-08-10	MT
Avita Medical Files US FDA Pre-Market Supplement Application for Skin Harvesting Device	23-06-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AViTA Corporation

Equities

4735

TW0004735006

Highlights

Filters